Prenosis

Prenosis Inc. is an artificial intelligence company based in Chicago, Illinois, founded in 2014. The company focuses on precision medicine in acute care, aiming to enhance patient outcomes by tailoring healthcare to individual biology through data-driven insights. Prenosis empowers clinicians to make biology-based decisions rather than relying solely on symptom-based diagnoses.

The company's flagship product, the Sepsis ImmunoScore™, is the first FDA De Novo-authorized AI diagnostic for sepsis. It provides real-time assessments and integrates smoothly into hospital workflows and electronic medical records. The Immunix™ platform captures extensive biomarker and clinical data, supporting the development of precision medicine tools and enabling real-time therapy optimization. Prenosis has partnered with Roche Diagnostics to distribute the Sepsis ImmunoScore™ through Roche's navify® Algorithm Suite platform, expanding its reach in U.S. hospitals.